ライフサイエンスコーパス: riboflavin

1 nsis in the presence of an electron shuttle (riboflavin).

2 ministration, plasma naltrexone, and urinary riboflavin.

3 corona phase, modulating the recognition of riboflavin.

4 milk and were 4-5 times higher than for free riboflavin.

5 al cofactor in the electron transport chain, riboflavin.

6 ns and initiated a regimen of high-dose oral riboflavin.

7 The most potent antidote was riboflavin.

8 and vitamins, such as biotin, thiamine, and riboflavin.

9 hanism is the lowest energy pathway yielding riboflavin.

10 role in the intracellular regulation of [3H]-riboflavin.

11 Escherichia coli, and an exogenous supply of riboflavin.

12 scued using a novel esterified derivative of riboflavin.

13 al, chlorpheniramine maleate, pyridoxine and riboflavin.

14 3% rose bengal; and Group IV, MRSA with 0.1% riboflavin.

15 CXL was performed using a mixed riboflavin 0.1% PBS solution followed by UVA irradiation

16 ntact epithelium were left for 45 minutes in riboflavin 0.1% solution and divided in the following gr

17 Cross-linking was performed by instilling riboflavin 0.1% solution containing 20% dextran for 15 m

18 m-off cross-linking procedure using standard riboflavin 0.1%-dextran 20% solutions.

19 20% solution; after repeated instillation of riboflavin 0.1%-dextran T 500 20% solution every 2.5 min

20 immediately after instillation of 2 drops of riboflavin 0.1%-dextran T 500 20% solution; after repeat

21 samples revealed lumichrome (4.7-10.0mg/kg), riboflavin (1.9-2.7mg/kg) and phenyllactic acid (112.1-2

22 irradiation alone; Group 4, riboflavin PDT (riboflavin + 375 nm irradiation); and Group 5, rose beng

23 iontophoresis device with dextran-free 0.1% riboflavin-5-phosphate solution with enhancers and by ir

24 4%, P = .01), thiamine (74.0%, P = .00), and riboflavin (73.3%, P = .01).

25 performed followed by accelerated CXL using riboflavin A and enhanced-intensity (30 mW/cm(2)) ultrav

26 to encode the ATPase component of a putative riboflavin ABC transport system.

27 It has been proposed that riboflavin absorption occurs through solute carrier fami

28 Autofluorescence was due to riboflavin accumulation in membrane-bounded cytoplasmic

29 n 'loaded' microbeads (361 mg/L) compared to riboflavin added to the microbead forming solution (48 m

30 dard CXL and the sham control group received riboflavin alone without removal of the epithelium.

31 ard CXL, and the sham control group received riboflavin alone without removal of the epithelium.

32 Riboflavin, also known as vitamin B2, is essential for c

33 he kinetics of immobilisation and release of riboflavin, amino acids and peptides from whey microbead

34 Riboflavin, an electron shuttle mediator naturally produ

35 Roseoflavin is a naturally occurring riboflavin analogue with antibiotic properties.

36 rent Km = 1.4 +/- 0.5 microM), inhibition by riboflavin analogues, and Na(+) independence.

37 gated for 30 minutes with a solution of 0.1% riboflavin and 20% dextran, followed by irradiation with

38 At baseline, increased dietary riboflavin and B12 were associated inversely with nuclea

39 rial dodecins bind the flavin FMN instead of riboflavin and exhibit a clearly different binding pocke

40 AIT T-cell antigen receptor (TCR) recognises riboflavin and folic acid metabolites bound by MR1 in a

41 Human urine samples containing riboflavin and its photolysis products were successfully

42 binding of the isoalloxazine heterocycle of riboflavin and its two cofactor forms, FMN and FAD.

43 statistical correlation was observed between riboflavin and lumichrome content.

44 s, acylcarnitines, purine, heme, bile acids, riboflavin and lysolipids.

45 oplasma-containing phagosome is limiting for riboflavin and pantothenate and that Histoplasma virulen

46 h NH4Cl in the presence of the photooxidants riboflavin and Rose Bengal as well as the diffusible one

47 metabolic capacity for de novo synthesis of riboflavin and so likely relies on scavenging riboflavin

48 bsequently be converted into isotope-labeled riboflavin and the cognate flavocoenzymes, FMN and FAD,

49 thesis and rfd1 contains reduced contents of riboflavin and the flavo-coenzymes FMN and FAD.

50 tide and 56%, 57% and 45% for the dipeptide, riboflavin and tryptophan respectively, however, the rat

51 Currently, corneal cross-linking by riboflavin and ultraviolet A (RFUVA) has received signif

52 ion to GA with increasing intake of thiamin, riboflavin, and folate after adjusting for age, sex, and

53 raquinone-2,6-disulfonate, hydroxocobalamin, riboflavin, and lawsone) was also tested.

54 cs, reducing sugar and B vitamins (thiamine, riboflavin, and niacin) content of steamed sprouts incre

55 requires several cofactors including biotin, riboflavin, and pantothenate.

56 c processes within the nodule (e.g., zeatin, riboflavin, and purine synthesis).

57 , niacin, phosphorus, potassium, folic acid, riboflavin, and vitamins B-12, C, and E, and by approxim

58 MHC class I-related molecule MR1 presents riboflavin- and folate-related metabolites to mucosal-as

59 rmediates from the microbial biosynthesis of riboflavin are recognized as signature biomarkers of mic

60 Despite the importance of riboflavin as the direct precursor of the cofactors flav

61 The average fluorescence intensity of riboflavin at a depth of 100, 150, 200, and 250 mum was

62 ape juices obtained from grapes treated with riboflavin at two different doses compared to control.

63 recognition by detecting infection with the riboflavin auxotroph Streptococcus pyogenes.

64 T TCRs in complex with MR1 bound to a potent riboflavin-based antigen (Ag) showed how variations in T

65 MAIT TCRs can bind folate- and riboflavin-based metabolites restricted by the major his

66 t after 30 minutes of UV-A exposure with the riboflavin biofilm in situ; and finally after washing th

67 ofilm in situ; and finally after washing the riboflavin biofilm.

68 initial reaction of the metabolic pathway of riboflavin biosynthesis and rfd1 contains reduced conten

69 avin kinase/regulator (RbkR), which controls riboflavin biosynthesis and transport genes in major lin

70 equential deamination and reduction steps in riboflavin biosynthesis are catalyzed by RibD, a bifunct

71 the conserved core of RbkR regulons includes riboflavin biosynthesis genes, known/predicted vitamin u

72 tion of genes coding for enzymes involved in riboflavin biosynthesis in M. truncatula and phenylpropa

73 Riboflavin biosynthesis in many Bacteria but not in Arch

74 a long-standing gap in understanding of the riboflavin biosynthesis in plants.

75 The riboflavin biosynthesis pathway has been shown to be ess

76 rt AtPyrP2 as the missing phosphatase on the riboflavin biosynthesis pathway in Arabidopsis thaliana.

77 ally relevant catalyst dephosphorylating the riboflavin biosynthesis pathway intermediate 5-amino-6-r

78 rt of co-regulation of genes of the T4SS and riboflavin biosynthesis pathway.

79 ponses against diverse microbes carrying the riboflavin biosynthesis pathway.

80 dition, we identified a bifunctional enzyme (riboflavin biosynthesis protein (RibD)), a putative func

81 Disruption of the RIB2 gene (riboflavin biosynthesis) prevented growth and proliferat

82 oteins together with a deaminase involved in riboflavin biosynthesis, the chloroplastic tRNA adenosin

83 found in Escherichia coli are related to the riboflavin biosynthetic pathway and display very limited

84 using Gram-negative bacteria mutated for the riboflavin biosynthetic pathway, we show a strict correl

85 The crystal structure of riboflavin-bound TmRibU reveals an electronegative bindi

86 sterol, microbiome, pyrroline-5-carboxylate, riboflavin, branch chain amino acid, peroxisomal, and mi

87 used by high rates of reoxidation of reduced riboflavin by oxygen produced during photosynthesis.

88 Importantly, supplementation of riboflavin can lead to significant clinical improvement

89 00 mg twice daily or matching placebo (50 mg riboflavin capsules), stratified by subtype (parkinsonia

90 vin catabolic strain, and the cloning of the riboflavin catabolic genes.

91 he isolation of a Microbacterium maritypicum riboflavin catabolic strain, and the cloning of the ribo

92 Based on these activities, a pathway for riboflavin catabolism is proposed.

93 purine, pyrimidine, isoprenoid, methionine, riboflavin, coenzyme A, and folate, as well as other bio

94 The main outcome measure was riboflavin concentration at the 3 evaluated depths.

95 enine oxidation signals was observed for the riboflavin concentration in the range of 0.5-70 mug mL(-

96 Riboflavin concentration was measured with high-performa

97 Slice depth-dependent decrease in riboflavin concentration was statistically significant (

98 Droplets containing a step change in riboflavin concentration were injected and mobilized by

99 l slices, presenting an evident reduction of riboflavin concentration with increasing depth in all gr

100 As the riboflavin concentrations increased from 0 to 100 ppm, t

101 Total riboflavin concentrations were also determined after aci

102 Free riboflavin concentrations were determined to 197 and 151

103 trovirals alone had no significant effect on riboflavin concentrations, they negatively affected the

104 The mean riboflavin content in the superficial slice in the epi-o

105 conus underwent standard epithelial-off UV-A/riboflavin CXL treatment with 30-minute UV-A exposure at

106 e have demonstrated differential folate- and riboflavin-derivative reactivity by a diverse population

107 Riboflavin did not retain statistical significance (P-tr

108 Corneal CXL with photoactivated riboflavin did not shorten the time to corneal healing;

109 in the near-infrared, as we show by tracking riboflavin diffusion in murine macrophages.

110 Exposure of riboflavin-doped liquid silk solution to light results i

111 d the highest concentrations when the lowest riboflavin dose was used.

112 To investigate whether the riboflavin dosing frequency affects corneal cross-linkin

113 ne was equivalent with 2-minute and 5-minute riboflavin dosing intervals at 6 months (0.97 and 0.76 d

114 pectively randomized to 2-minute or 5-minute riboflavin dosing intervals with standard corneal cross-

115 The 2 riboflavin dosing regimens produced equivalent reduction

116 sporter homologue revealed reduced levels of riboflavin, downstream metabolites, and electron transpo

117 lavin transporter gene defects, and validate riboflavin esters as a potential therapeutic strategy.

118 seline, at 1 month and 3 months after CXL or riboflavin eyedrops, and again at 1-, 3-, 6-, 12-, and 2

119 ior of the naturally occurring vitamin B(2), riboflavin (Fl(ox)), was examined in detail in dimethyl

120 urally occurring flavin derivatives, such as riboflavin, FMN, and FAD, as well as lumichrome, a photo

121 lencing of AtPyrP2 decreased accumulation of riboflavin, FMN, and FAD.

122 Dietary intakes of riboflavin, folate, choline, and betaine varied signific

123 Reference Nutrient Intakes of beta-carotene, riboflavin, folate, vitamin B-12, calcium, and iron (con

124 (e.g., palmitic acid), quinolone signal, and riboflavin fragments were found to respond after the bio

125 Recombinant ppBat was used to capture riboflavin from bovine milk directly without any prior p

126 iboflavin and so likely relies on scavenging riboflavin from the host environment.

127 of substrate binding by the EcfS subunit for riboflavin from Thermotoga maritima, TmRibU.

128 For vitamin B2 (riboflavin), GM Bacillus subtilis production strains hav

129 66, 0.99, respectively) and total intakes of riboflavin (HR: 0.81; 95% CI: 0.66, 0.99) were associate

130 inase, riboflavin reductase, ribokinase, and riboflavin hydrolase, respectively.

131 It is biosynthesized from riboflavin in a reaction involving replacement of the C8

132 d daily intake/100g (RDI), respectively) and riboflavin in almonds (119% of the RDI).

133 rinks and of caffeine, Class III caramel and riboflavin in energy drinks using synchronous fluorescen

134 amenable to develop a direct assay for free riboflavin in milk and other foods.

135 nspired by the propensity of crystalline (-)-riboflavin in the eyes of vertebrates to invert the intr

136 ate pathways and a probable limiting role of riboflavin in these processes and a higher SAM/SAH ratio

137 Riboflavin increased the rate of Te(IV) reduction eleven

138 et size on the stability of the emulsions to riboflavin-induced lipid oxidation during storage at 20

139 stability of fish oil-in-water emulsions to riboflavin-induced oxidation by blending different combi

140 ion was applied for 30 minutes, during which riboflavin instillation was repeated every 3 minutes.

141 d without cataract, persons with the highest riboflavin intake versus those with the lowest intake ha

142 Vitamin B-6 and riboflavin intakes from diet and supplements were associ

143 und treatment increased the entry of topical riboflavin into the corneal stroma despite the presence

144 ion of extracellular metal oxides, including riboflavin, iron-bound heme and heme biosynthetic interm

145 Riboflavin is a common cofactor, and its biosynthetic pa

146 Riboflavin is a critical metabolite enabling all organis

147 bolic processes in all living organisms, and riboflavin is a direct precursor of the cofactors FMN an

148 -containing flavoprotein, and treatment with riboflavin is advisable.

149 Although riboflavin is an essential nutrient, why mutations in it

150 The cofactor riboflavin is biochemically synthesized by a constitutio

151 nduced by wavelengths >500 nm, and that also riboflavin is contributing from 400 to 500 nm.

152 At a scan rate of 0.1 V s(-1), riboflavin is initially reduced by one electron to form

153 where the number of interfering species for riboflavin is much fewer.

154 Cytoplasmic riboflavin is rapidly and almost completely converted to

155 Compared to the other redox probes, riboflavin is superior in its oxidization in negative po

156 Vitamin B2 (riboflavin) is essential for metabolic functions and is

157 screte photochemical activation modes of (-)-riboflavin, it is possible to sequentially induce isomer

158 d in two independent modules; The C-terminal riboflavin kinase (RFK) catalyzes the RFK activity, whil

159 The DNA motifs and CTP-dependent riboflavin kinase activity of two RbkR proteins were exp

160 RbkR proteins are composed of the riboflavin kinase domain and a DNA-binding winged helix-

161 expressed and biochemically characterized as riboflavin kinase, riboflavin reductase, ribokinase, and

162 d by CTP and suppressed by FMN, a product of riboflavin kinase.

163 We identified a novel bifunctional riboflavin kinase/regulator (RbkR), which controls ribof

164 ropolymer-nanotube recognition complexes for riboflavin, L-thyroxine and oestradiol.

165 ters in animals that were maintained in high riboflavin levels.

166 To overcome riboflavin loss, a second approach to 'load' whey microb

167 In summary, riboflavin may be a novel treatment for cyanide toxicity

168 No other experimental groups, including riboflavin-mediated PDT, had any inhibitory effect on th

169 Rose bengal- and riboflavin-mediated photodynamic therapy demonstrated co

170 re disease, when associated with disorder of riboflavin metabolism, may be treatable has raised aware

171 A unique pathway, riboflavin metabolism, was active at the 4 week time poi

172 by RibR is to couple sulfur metabolism with riboflavin metabolism.

173 on of MR1 and the limited known diversity of riboflavin metabolite antigens have suggested that MAIT

174 cell receptors (TCRs) that are activated by riboflavin metabolite-based antigens (Ag) presented by t

175 distinct TCRs responded differentially to a riboflavin metabolite.

176 n and mouse MR1 were found to bind bacterial riboflavin metabolites (ribityllumazine [RL] Ags) capabl

177 Since riboflavin metabolites are critical components of the mi

178 MAIT cells recognize microbial riboflavin metabolites of bacterial or fungal origin pre

179 As known MAIT antigens are derived from riboflavin metabolites, this suggests that TRAV12-2(+) c

180 lin TE (n = 35) or epi-off CXL with isotonic riboflavin (n = 26) in 1 academic treatment center, usin

181 commended Nutrient Intake (RNI) for thiamin, riboflavin, niacin, folate, vitamin B-12, calcium, iron,

182 e Recommended Dietary Allowances of thiamin, riboflavin, niacin, pyridoxine, and vitamin B-12.

183 Riboflavin normalizes many of the cyanide-induced neurol

184 rming solution however diffusional losses of riboflavin occurred during the subsequent bead preparati

185 FAD degradation to riboflavin occurs via still poorly characterized enzymes

186 de value were used to evaluate the effect of riboflavin on the photo-oxidation of vegetable oil in sa

187 ial suspensions were mixed with rose bengal, riboflavin, or water according to experimental group.

188 mong women with high intakes of thiamine and riboflavin (P < 0.05).

189 of energy (P = .04), thiamine (P = .02), and riboflavin (P = .01).The proportion of stunted children

190 Riboflavin, pantothenate, and biotin auxotrophs of Histo

191 alyzes one of the two committed steps in the riboflavin pathway and converts d-ribulose 5-phosphate (

192 Importantly, the riboflavin pathway is absent in B. malayi.

193 Group 3, 518 nm irradiation alone; Group 4, riboflavin PDT (riboflavin + 375 nm irradiation); and Gr

194 The current method is capable of riboflavin peak % relative standard deviations (RSDs) do

195 Recombinant tcvSOD also inhibited a riboflavin photochemical reduction system in a polyacryl

196 (Me)C and the preferential intercalation of riboflavin photosensitizer adjacent to (Me)C:G base pair

197 ity to synthesize the 5-amino-ribityl-uracil riboflavin precursor and to activate polyclonal and quas

198 Although riboflavin precursor derivatives from Gram-positive bact

199 D and MR1, present glycolipids and microbial riboflavin precursor derivatives, respectively, to T cel

200 isotope-labeled purine supplements into the riboflavin precursor, 6,7-dimethyl-8-ribityllumazine, wi

201 Riboflavin precursors found in many bacteria and yeast a

202 gnize derivatives of precursors of bacterial riboflavin presented by the major histocompatibility com

203 respect to the standard protocol (30-minute riboflavin presoak, 3 mW/cm(2) ultraviolet illumination

204 lt in fatty acid synthesis and inhibition of riboflavin production.

205 ith the addition of riboflavin, showing that riboflavin protected the oil in salad dressing from phot

206 photobleaching of photosensitizers in milk (riboflavin, protoporphyrin IX and a chlorophyllic compou

207 ) PyrR (At3g47390 or GRMZM2G090068) restored riboflavin prototrophy to an E. coli ribD deletant strai

208 Baseline serum riboflavin, pyridoxal phosphate (PLP), folate, vitamin B

209 Thiamine, riboflavin, pyridoxine, lutein, zeaxanthin, beta-caroten

210 emically characterized as riboflavin kinase, riboflavin reductase, ribokinase, and riboflavin hydrola

211 SCL52A3 mutations may be good candidates for riboflavin replacement therapy and suggests that either

212 ine, Class III caramel, Class IV caramel and riboflavin, respectively.

213 n similar to what has been reported in other riboflavin-responsive inborn errors of metabolism.

214 The riboflavin (RF) cofactors, flavin adenine dinucleotide (

215 eal flap, a protocol using fibrinogen (FIB), riboflavin (RF), and ultraviolet (UVA) light (FIB+RF+UVA

216 Tissue glue containing fibrinogen (FIB) and riboflavin (RF), upon exposure to long wavelength ultrav

217 membrane protein that transports vitamin B2 (riboflavin, RF) into cells, and thus, plays a role in co

218 different mediators (hexacyanoferrate, HCF, riboflavin, RF) were characterized by stepwise shifting

219 ogically derived proton-active redox center, riboflavin (RFN).

220 onsible for biosynthesis and/or transport of riboflavin (rib genes).

221 istance gene, the deletion of the endogenous riboflavin (rib) operon and presence of four putative pl

222 ly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a pheno

223 oresis imbibition yielded greater and deeper riboflavin saturation with respect to conventional epi-o

224 Both changes in biofilm formation and riboflavin secretion are supported by changes in gene ex

225 lowly in the presence of TiO2 nanoparticles, riboflavin secretion, a function related to the S. oneid

226 formation, a general bacteria function, and riboflavin secretion, a species-specific function, were

227 functional assessments of biofilm formation, riboflavin secretion, and gene expression, has implicati

228 Riboflavin showed almost complete inhibition with UV-A i

229 imultaneously decreased with the addition of riboflavin, showing that riboflavin protected the oil in

230 coefficients are obtained for acetazolamide, riboflavin, sodium fluorescein, and theophylline in 2-hy

231 king efficacy or safety, given that isotonic riboflavin solution is viscous and each installation coa

232 Eyes were removed from the riboflavin solution, corneas were excised, and group B w

233 ld be reexpanded with hypotonic dextran-free riboflavin solutions.

234 uence treatment response and outcome include riboflavin status and how well the foetus has been suppl

235 of this SLC52A2-specific cohort suggest that riboflavin supplementation can ameliorate the progressio

236 t also forms cage complexes with the cognate riboflavin synthase (AaRS) when both proteins are co-pro

237 s subtilis (BsLS), for example, encapsulates riboflavin synthase (BsRS), enabling channeling of lumaz

238 nding O-nucleosides as lumazine synthase and riboflavin synthase inhibitors, while the C-nucleosides

239 Therefore, enzymes involved in riboflavin synthesis are considered as potential antibac

240 is PyrR gene (At3g47390) is coexpressed with riboflavin synthesis genes.

241 (5-A-RU), an early intermediate in bacterial riboflavin synthesis.

242 With free riboflavin, the opposite is the case.

243 In the presence of riboflavin, the phototrophic biomass in the anodic compa

244 THFR) was responsive to supplementation with riboflavin-the cofactor for MTHFR.

245 The oxidized riboflavin then diffuses away from the particle, establi

246 and we report the response to high-dose oral riboflavin therapy in patients with SLC52A2 mutations, i

247 encephalomyopathy and responded favorably to riboflavin therapy.

248 red to those in the lowest quartile of serum riboflavin, those in the highest had a 44% lower risk of

249 In vitro, retbindin is capable of binding riboflavin, thus implicating the protein as a metabolite

250 examination of rft-1 showed its transport of riboflavin to have an acidic pH dependence, saturability

251 ransport chain, we hypothesized that reduced riboflavin transport would result in impaired mitochondr

252 Two potential orthologs of the human riboflavin transporter 3 (hRFVT3) were identified in the

253 l dysfunction as a downstream consequence of riboflavin transporter gene defects, and validate ribofl

254 Loss-of-function mutations in two riboflavin transporter genes, SLC52A2 and SLC52A3, have

255 ckdown of the single Drosophila melanogaster riboflavin transporter homologue revealed reduced levels

256 Riboflavin transporter knockdown in Drosophila also resu

257 we confirmed the strong genetic link between riboflavin transporter mutations and Brown-Vialetto-Van

258 europathology and downstream consequences of riboflavin transporter mutations are unclear.

259 cause reduced riboflavin uptake and reduced riboflavin transporter protein expression, and we report

260 rted the identification of SLC52A2, encoding riboflavin transporter RFVT2, as a new causative gene fo

261 The human SLC52A1 gene encodes the riboflavin transporter-1 (RFVT-1), a plasma membrane pro

262 for the first time the identification of two riboflavin transporters in C. elegans and demonstrate th

263 system demonstrated that both were specific riboflavin transporters, although the rft-1 encoded prot

264 52A2 and SLC52A3 genes, both of which encode riboflavin transporters.

265 hat patients with SLC52A3 defects respond to riboflavin treatment clinically and biochemically.

266 and hue had significant differences when the riboflavin treatments were applied.

267 g effects are concentration dependent on the riboflavin-tryptophan complex and the NO release rate fr

268 A riboflavin-tryptophan complex found in the media was ide

269 Forty eyes underwent riboflavin-ultraviolet A-induced CXL.

270 isomerization of activated olefins using (-)-riboflavin (up to 99:1 Z/E).

271 anodic current generation in the presence of riboflavin upon illumination of a mixed phototrophic cul

272 nstrate that SLC52A2 mutations cause reduced riboflavin uptake and reduced riboflavin transporter pro

273 Riboflavin uptake by the microbeads was shown to be via

274 udy whey microbeads were used to encapsulate riboflavin using 2 methods.

275 Ten patients underwent epithelium-off riboflavin/UV-A corneal cross-linking at Siena Universit

276 Riboflavin (vitamin B(2)) and its metabolite lumichrome

277 Riboflavin (vitamin B(2)) is the precursor of the flavin

278 rode, increasing the interaction between the Riboflavin (vitamin B2) and the SERS active electrode.

279 link silk fibroin protein is reported, using riboflavin (vitamin B2) as a photoinitiator and the mech

280 ogate under UV-irradiation (402 nm) with (-)-riboflavin (vitamin B2) as an inexpensive, organic photo

281 Riboflavin (vitamin B2) is the precursor of flavin monon

282 tudy the influence of foliar applications of riboflavin (vitamin B2) to vineyard on grape nitrogen co

283 ain-specific auxotrophies were predicted for riboflavin (vitamin B2), guanosine, leucine, methionine,

284 intakes and blood biomarkers were found for riboflavin, vitamin B-6, active vitamin B-12 (holotransc

285 ated associations between intakes of folate, riboflavin, vitamin B-6, and vitamin B-12 and colorectal

286 e assessment of folate, choline, methionine, riboflavin, vitamin B-6, vitamin B-12, and alcohol intak

287 The overall stromal concentration of riboflavin was 34.1 +/- 7.1 mug/g in epi-off, 7.2 +/- 3.

288 Riboflavin was added to the microbead forming solution h

289 oach to 'load' whey microbeads by soaking in riboflavin was assessed.

290 outward, creating a clear zone within which riboflavin was detected by mass spectrometry.

291 These data show that riboflavin was more effective at promoting oxidation in

292 Riboflavin was used as a biological molecule with inhere

293 oof-of-concept and characterize performance, riboflavin was used as a biologically relevant model mol

294 cteria, Treponema pallidum cannot synthesize riboflavin; we recently described a flavin-uptake mechan

295 In addition, dietary folacin and riboflavin were inversely associated with diastolic BP.

296 gnificantly (p0.05) higher concentrations of riboflavin were obtained in 'loaded' microbeads (361 mg/

297 iduals with a milder phenotype responsive to riboflavin were shown to have single amino acid changes

298 ressings with 0, 5, 20, 50 and 100 ppm added riboflavin were stored under light (2500 lux) at 25 degr

299 TmRibU binds riboflavin with high affinity, and the protein-substrate

300 chieving clinically useful concentrations of riboflavin within the cornea with minimum epithelial dam